SHUTTLE PHARMACTCLS HLDGS INC Financials
This page shows SHUTTLE PHARMACTCLS HLDGS INC (SHPH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
SHUTTLE PHARMACTCLS HLDGS INC passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, SHUTTLE PHARMACTCLS HLDGS INC generates $0.80 in operating cash flow (-$7.3M OCF vs -$9.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
SHUTTLE PHARMACTCLS HLDGS INC earns $-77.0 in operating income for every $1 of interest expense (-$7.7M vs $100K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
SHUTTLE PHARMACTCLS HLDGS INC's EBITDA was -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 30.7% from the prior year.
SHUTTLE PHARMACTCLS HLDGS INC reported -$9.1M in net income in fiscal year 2024. This represents a decrease of 38.7% from the prior year.
SHUTTLE PHARMACTCLS HLDGS INC earned $-3.30 per diluted share (EPS) in fiscal year 2024. This represents an increase of 6.5% from the prior year.
SHUTTLE PHARMACTCLS HLDGS INC held $1.9M in cash against $0 in long-term debt as of fiscal year 2024.
SHUTTLE PHARMACTCLS HLDGS INC had 163,093 shares outstanding in fiscal year 2024. This represents a decrease of 91.9% from the prior year.
SHUTTLE PHARMACTCLS HLDGS INC invested $3.6M in research and development in fiscal year 2024. This represents an increase of 2.9% from the prior year.
SHPH Income Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $943K-32.6% | $1.4M | N/A | $1.0M | N/A | $669K | N/A | $187K |
| SG&A Expenses | $886K+169.3% | $329K | N/A | $266K | N/A | $82K | N/A | $6K |
| Operating Income | -$2.3M+25.7% | -$3.1M | N/A | -$1.6M | N/A | -$821K | N/A | -$242K |
| Interest Expense | N/A | $387K | N/A | $623K | N/A | $605K | N/A | $113 |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$2.3M+38.0% | -$3.8M | N/A | -$1.8M | N/A | -$998K | N/A | -$217K |
| EPS (Diluted) | $-1.05 | $-39.83 | N/A | $-0.91 | N/A | $-0.10 | N/A | N/A |
SHPH Balance Sheet
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.5M+41.4% | $2.5M-57.9% | $6.0M-19.3% | $7.4M-14.8% | $8.7M-7.8% | $9.4M+1339.8% | $652K | N/A |
| Current Assets | $3.3M+47.7% | $2.2M-60.5% | $5.6M-20.0% | $7.0M-18.5% | $8.6M-7.7% | $9.3M+1722.8% | $510K | N/A |
| Cash & Equivalents | $2.1M+9.1% | $1.9M-25.5% | $2.6M-33.7% | $3.9M-53.8% | $8.4M-7.7% | $9.1M+1706.9% | $505K | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | $6K | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.1M+19.6% | $1.8M-5.2% | $1.9M+7.4% | $1.8M+81.0% | $976K-0.1% | $977K-59.6% | $2.4M | N/A |
| Current Liabilities | $2.0M+28.1% | $1.5M+47.2% | $1.0M+28.6% | $810K-16.9% | $976K+0.5% | $970K-56.2% | $2.2M | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $91K | N/A |
| Total Equity | $1.4M+96.6% | $709K-82.5% | $4.1M-27.7% | $5.6M-26.9% | $7.7M-8.6% | $8.4M+576.4% | -$1.8M+15.7% | -$2.1M |
| Retained Earnings | -$43.7M-26.3% | -$34.6M-36.0% | -$25.4M-6.9% | -$23.8M-26.3% | -$18.8M-131.3% | -$8.1M+41.2% | -$13.8M | N/A |
SHPH Cash Flow Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.6M+2.4% | -$2.7M-153.3% | -$1.1M+30.8% | -$1.5M-141.4% | -$636K+39.5% | -$1.1M-677.3% | -$135K | N/A |
| Capital Expenditures | N/A | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | -$1.1M | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | $0-100.0% | $87K+436.6% | -$26K | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$96K-102.2% | $4.5M+1431.7% | -$334K | $0+100.0% | -$67K-100.7% | $10.1M+1944.9% | $495K | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SHPH Financial Ratios
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q4'21 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -66.3%+495.6pp | -561.8% | N/A | -24.3% | N/A | -10.6% | N/A | N/A |
| Current Ratio | 1.66+0.2 | 1.44-3.9 | 5.37-3.3 | 8.63-0.2 | 8.79-0.8 | 9.57+9.3 | 0.23 | N/A |
| Debt-to-Equity | 1.54-1.0 | 2.53+2.1 | 0.47+0.2 | 0.31+0.2 | 0.13+0.0 | 0.12+0.2 | -0.05 | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is SHUTTLE PHARMACTCLS HLDGS INC profitable?
No, SHUTTLE PHARMACTCLS HLDGS INC (SHPH) reported a net income of -$9.1M in fiscal year 2024.
What is SHUTTLE PHARMACTCLS HLDGS INC's earnings per share (EPS)?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) reported diluted earnings per share of $-3.30 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is SHUTTLE PHARMACTCLS HLDGS INC's EBITDA?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had EBITDA of -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is SHUTTLE PHARMACTCLS HLDGS INC's operating cash flow?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) generated -$7.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are SHUTTLE PHARMACTCLS HLDGS INC's total assets?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had $2.5M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does SHUTTLE PHARMACTCLS HLDGS INC spend on research and development?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) invested $3.6M in research and development during fiscal year 2024.
How many shares does SHUTTLE PHARMACTCLS HLDGS INC have outstanding?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had 163,093 shares outstanding as of fiscal year 2024.
What is SHUTTLE PHARMACTCLS HLDGS INC's current ratio?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had a current ratio of 1.44 as of fiscal year 2024, which is considered adequate.
What is SHUTTLE PHARMACTCLS HLDGS INC's debt-to-equity ratio?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had a debt-to-equity ratio of 2.53 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SHUTTLE PHARMACTCLS HLDGS INC's return on assets (ROA)?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had a return on assets of -364.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is SHUTTLE PHARMACTCLS HLDGS INC's cash runway?
Based on fiscal year 2024 data, SHUTTLE PHARMACTCLS HLDGS INC (SHPH) had $1.9M in cash against an annual operating cash burn of $7.3M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is SHUTTLE PHARMACTCLS HLDGS INC's Piotroski F-Score?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are SHUTTLE PHARMACTCLS HLDGS INC's earnings high quality?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) has an earnings quality ratio of 0.80x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can SHUTTLE PHARMACTCLS HLDGS INC cover its interest payments?
SHUTTLE PHARMACTCLS HLDGS INC (SHPH) has an interest coverage ratio of -77.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.